Exciting news from Health Canada! They’ve broadened the approval of Jemperli (dostarlimab) in combination with chemotherapy for all adults facing primary advanced or first recurrent endometrial cancer. This groundbreaking treatment is the first in immuno-oncology to show a remarkable overall survival benefit.
Browsing: cancer research
The International Atomic Energy Agency (IAEA) has commenced a visit to India aimed at enhancing collaboration in nuclear energy and cancer treatment. This initiative underscores the importance of safe nuclear technology for sustainable development and healthcare advancements.
A recent Lancet report highlights a groundbreaking cancer therapy that has shown promising results, achieving a 73% success rate in clinical trials among Indian patients. This significant finding could revolutionize treatment options in India and beyond.